Bain Capital
Bain Capital is a Boston-based multi-asset alternative investment firm that sources, funds, and manages investments across private equity, venture capital, credit, and public equity. Founded in 1984, it operates globally with specialized units focused on growth and buyout investments, life sciences, and impact-oriented opportunities. The firm backs companies across sectors including healthcare and life sciences, technology, software and data services, financial services, consumer, manufacturing, and industrials, spanning from early-stage ventures to growth equity and large-scale acquisitions. It emphasizes value creation through strategic support and partnerships, leveraging deep operating experience and a global network. Its life sciences arm targets pharmaceutical, biotechnology, medical device, and diagnostic companies; the Double Impact unit pursues market-rate returns alongside measurable social and environmental benefits; Bain Capital Ventures backs technology-enabled businesses from seed to growth across enterprise software, infrastructure, and services. The firm maintains offices in Boston and major markets worldwide, aiming to deliver competitive returns while supporting innovation and economic development.
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Jennifer Davis
Partner, Private Equity, Consumer and Retail Vertical and Member of the North American Private Equity Team
Liraz Evenor
Managing Director Private Equity and Director in the Consumer and Retail Vertical & Member of the Portfolio Group for North America Private Equity
Alison Holmes
Principal, Private Equity and Consumer, Retail and Dining Vertical & Member of the North American Private Equity Team
Andrew Kaplan
Partner, Private Equity and Healthcare Vertical and Member Of The North American Private Equity Team
Christopher Kastner
Managing Director, Portfolio Group and Member of the North American Private Equity team
Phillip Loughlin
Partner, Global Head of the Financial and Business Services Vertical and Member of the Consumer / Retail Vertical
James Mackey
Principal, Private Equity and Technology Vertical and Member of the North American Private Equity Team
Giacomo Massetti
Managing Director, Consumer and Industrial Verticals and Member of the European Private Equity team
Cara Nealon
Senior Vice President, Portfolio Group and Member of the North American Private Equity Team
Radhika Subramanian
Principal, Consumer, Retail and Financial services and a Member of the Asia Pacific Private Equity team
Past deals in Pennsylvania
Lincoln Financial Group
Post in 2025
Founded in 1905, Lincoln Financial Group is a Fortune 500 company offering a diverse range of financial services and solutions, including investments, asset management, mutual funds, annuities, alternative investments, brokerage solutions, life insurance, retirement planning, and group benefits.
Century Therapeutics
Post in 2024
Century Therapeutics is a biotechnology company developing allogeneic cell therapies derived from induced pluripotent stem cells to treat cancer and related diseases. Its platform enables engineering of iPSCs into NK and T cells with master cell banks of modified cells that can be expanded and differentiated into standardized, off-the-shelf therapies. The company combines CRISPR-mediated gene editing, proprietary chimeric antigen receptors, Allo-Evasion technology, and manufacturing capabilities to enable scalable production of homogeneous cell products for hematologic and solid tumors. While focused on oncology, its platform also targets autoimmune and inflammatory diseases with the goal of improving cell therapy performance and reducing host immune rejection.
Areteia Therapeutics
Series A in 2024
Areteia Therapeutics is a biotechnology company focused on developing oral therapies for eosinophilic asthma to improve disease control. The company was spun out of Knopp and is advancing an oral drug designed to inhibit eosinophil maturation, aiming to reduce inflammation and alleviate symptoms of severe asthma. Phase 2 data from its program indicated the oral candidate lowers blood eosinophil counts, a marker associated with better lung function. By pursuing an oral, non-injectable treatment option, Areteia seeks to offer a convenient alternative to injectable therapies and broaden access for asthma patients. The company’s work centers on targeting eosinophil-related pathways to enhance asthma management and patient quality of life.
Areteia Therapeutics
Series A in 2022
Areteia Therapeutics is a biotechnology company focused on developing oral therapies for eosinophilic asthma to improve disease control. The company was spun out of Knopp and is advancing an oral drug designed to inhibit eosinophil maturation, aiming to reduce inflammation and alleviate symptoms of severe asthma. Phase 2 data from its program indicated the oral candidate lowers blood eosinophil counts, a marker associated with better lung function. By pursuing an oral, non-injectable treatment option, Areteia seeks to offer a convenient alternative to injectable therapies and broaden access for asthma patients. The company’s work centers on targeting eosinophil-related pathways to enhance asthma management and patient quality of life.
Hand In Hand Soap
Funding Round in 2021
Hand In Hand Soap, founded in 2011 by Bill Glaab and Courtney Apple, is a personal care brand based in Wynnewood, Pennsylvania. The company specializes in a range of products including bar soap, liquid hand soap, hand sanitizer, body wash, sugar scrubs, and lotions. Committed to social responsibility, Hand In Hand operates a Give Back program, donating a bar of soap and access to clean water for every product sold, resulting in over 13 million bars of soap and significant contributions to water access for children in need. Additionally, the company prioritizes sustainability by producing palm oil-free products and actively educating consumers about the environmental and human rights issues associated with palm oil production.
Marinus Pharmaceuticals
Post in 2019
Marinus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics for rare seizure disorders and neuropsychiatric conditions. The company's lead product candidate, ganaxolone, functions as an allosteric modulator of GABAA receptors and is being developed in both intravenous and oral formulations for use in various patient populations, including adults and children. Ganaxolone is targeted for multiple indications, such as status epilepticus, cyclin dependent kinase like 5 deficiency disorder, PCDH19-related epilepsy, tuberous sclerosis complex, postpartum depression, and treatment-resistant depression. Marinus Pharmaceuticals emphasizes collaboration with healthcare professionals and partners to enhance patient care and improve the lives of those affected by these conditions. Founded in 2003 and headquartered in Radnor, Pennsylvania, the company is committed to advancing its therapeutic offerings through rigorous scientific research and development.
Idelic
Series A in 2019
Idelic is a driver management platform based in Pittsburgh, Pennsylvania, founded in 2016. The company specializes in consolidating fleet data systems and automating compliance processes within the transportation industry. Its platform integrates data from various technology sources into a unified system, allowing clients to efficiently manage safety operations and gain predictive insights. By leveraging data organization and artificial intelligence, Idelic aims to enhance driver safety, reduce turnover, and lower insurance costs, ultimately helping to prevent crashes and improve overall fleet performance.
Idelic
Seed Round in 2018
Idelic is a driver management platform based in Pittsburgh, Pennsylvania, founded in 2016. The company specializes in consolidating fleet data systems and automating compliance processes within the transportation industry. Its platform integrates data from various technology sources into a unified system, allowing clients to efficiently manage safety operations and gain predictive insights. By leveraging data organization and artificial intelligence, Idelic aims to enhance driver safety, reduce turnover, and lower insurance costs, ultimately helping to prevent crashes and improve overall fleet performance.
Penn Foster
Acquisition in 2018
Founded in 1890, Penn Foster is a global leader in online education, offering career-focused degree programs and vocational training. It operates through Penn Foster College, Career School, and High School, providing accredited courses in allied health, business, technology, education, and select trades.
Marinus Pharmaceuticals
Post in 2017
Marinus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics for rare seizure disorders and neuropsychiatric conditions. The company's lead product candidate, ganaxolone, functions as an allosteric modulator of GABAA receptors and is being developed in both intravenous and oral formulations for use in various patient populations, including adults and children. Ganaxolone is targeted for multiple indications, such as status epilepticus, cyclin dependent kinase like 5 deficiency disorder, PCDH19-related epilepsy, tuberous sclerosis complex, postpartum depression, and treatment-resistant depression. Marinus Pharmaceuticals emphasizes collaboration with healthcare professionals and partners to enhance patient care and improve the lives of those affected by these conditions. Founded in 2003 and headquartered in Radnor, Pennsylvania, the company is committed to advancing its therapeutic offerings through rigorous scientific research and development.
4moms
Venture Round in 2015
4moms is a company based in Pittsburgh, Pennsylvania, that specializes in developing innovative robotics technology-based products for children from prenatal to preschool age. The company focuses on addressing the real needs of parents by creating advanced juvenile products. Its diverse product line includes various baby and kids items, such as gear, toys, and clothing. With a dedicated team of over forty engineers, designers, and developers, 4moms has successfully established its presence in more than 500 retail locations across 24 countries. By leveraging robotics technology, 4moms aims to enhance the experience of parenting within the growing juvenile products industry, which is valued at approximately 8.9 billion dollars in the U.S.
Dynamics
Series C in 2014
Dynamics Inc. designs and manufactures interactive payment cards that utilize programmable magnetic stripes to enhance electronic payment systems. Founded in 2007 and headquartered in Cheswick, Pennsylvania, the company offers a range of products, including multi-purpose security and loyalty cards for banks, as well as loyalty systems for merchants and health cards for consumers. Dynamics' technology allows for customizable features, providing enhanced choice, control, convenience, and security in transactions. The company has established strategic partnerships with SoftBank Corp. and its subsidiary. Dynamics operates as a subsidiary of Canadian Imperial Bank of Commerce, focusing on transforming payment methods through innovative card solutions.
4moms
Series B in 2014
4moms is a company based in Pittsburgh, Pennsylvania, that specializes in developing innovative robotics technology-based products for children from prenatal to preschool age. The company focuses on addressing the real needs of parents by creating advanced juvenile products. Its diverse product line includes various baby and kids items, such as gear, toys, and clothing. With a dedicated team of over forty engineers, designers, and developers, 4moms has successfully established its presence in more than 500 retail locations across 24 countries. By leveraging robotics technology, 4moms aims to enhance the experience of parenting within the growing juvenile products industry, which is valued at approximately 8.9 billion dollars in the U.S.
4moms
Series A in 2012
4moms is a company based in Pittsburgh, Pennsylvania, that specializes in developing innovative robotics technology-based products for children from prenatal to preschool age. The company focuses on addressing the real needs of parents by creating advanced juvenile products. Its diverse product line includes various baby and kids items, such as gear, toys, and clothing. With a dedicated team of over forty engineers, designers, and developers, 4moms has successfully established its presence in more than 500 retail locations across 24 countries. By leveraging robotics technology, 4moms aims to enhance the experience of parenting within the growing juvenile products industry, which is valued at approximately 8.9 billion dollars in the U.S.
Dynamics
Series B in 2011
Dynamics Inc. designs and manufactures interactive payment cards that utilize programmable magnetic stripes to enhance electronic payment systems. Founded in 2007 and headquartered in Cheswick, Pennsylvania, the company offers a range of products, including multi-purpose security and loyalty cards for banks, as well as loyalty systems for merchants and health cards for consumers. Dynamics' technology allows for customizable features, providing enhanced choice, control, convenience, and security in transactions. The company has established strategic partnerships with SoftBank Corp. and its subsidiary. Dynamics operates as a subsidiary of Canadian Imperial Bank of Commerce, focusing on transforming payment methods through innovative card solutions.
Helomics Corporation
Series D in 2010
Helomics Corporation is a personalized healthcare company that develops diagnostic and tumor profiling solutions to guide cancer treatment decisions. Its Precision Cellular Analytical Platform analyzes cell cycle and proliferation data over a multiweek timeframe to support physicians in selecting effective therapies. The company offers products including ChemoFx for gynecologic cancers, BioSpeciFx biomarker tests to evaluate tumor biology and potential drug response or prognosis, GeneFx Colon for stage II colon cancer, and GeneFx Lung for early stage non-small cell lung cancer. It also provides tumor profiling services such as bioinformatics, contract research and development, and biorepository and banking. Helomics collaborates with industry partners to advance personalized oncology insights. The company was founded in 1995 and is based in Pittsburgh, Pennsylvania.
Celerion
Seed Round in 2010
Celerion is a clinical research organization that specializes in early-stage clinical trials and applied translational medicine services for pharmaceutical and biotechnology companies worldwide. Founded in 2010 and headquartered in Lincoln, Nebraska, with additional locations in Tempe, Arizona, and West Conshohocken, Pennsylvania, Celerion focuses on translating research discoveries into actionable insights about drug effects in humans to support early drug development decisions. The company offers a range of services including global clinical research, data management, biometrics, bioanalytical services, and drug development solutions. With over 600 beds for clinical trials and experienced scientific staff, Celerion aims to expedite the market entry of new medicines through innovative strategies and efficient data generation.
Celerion
Acquisition in 2010
Celerion is a clinical research organization that specializes in early-stage clinical trials and applied translational medicine services for pharmaceutical and biotechnology companies worldwide. Founded in 2010 and headquartered in Lincoln, Nebraska, with additional locations in Tempe, Arizona, and West Conshohocken, Pennsylvania, Celerion focuses on translating research discoveries into actionable insights about drug effects in humans to support early drug development decisions. The company offers a range of services including global clinical research, data management, biometrics, bioanalytical services, and drug development solutions. With over 600 beds for clinical trials and experienced scientific staff, Celerion aims to expedite the market entry of new medicines through innovative strategies and efficient data generation.
Regulatory Datacorp
Venture Round in 2009
Regulatory DataCorp, Inc. is a provider of governance, risk, and compliance solutions, primarily catering to Fortune 100 companies across diverse industries. Established in 2002 and headquartered in King of Prussia, Pennsylvania, with an additional office in Singapore, the company specializes in delivering precise risk alerts and ongoing monitoring to enhance protection and performance. Its range of services includes anti-money laundering, know your customer, anti-bribery and corruption, and supplier due diligence. The company serves a wide array of sectors, including banking, insurance, e-commerce, energy, automotive, and technology, assisting financial institutions and high-risk corporations in achieving superior risk-screening outcomes while ensuring regulatory compliance.
Regulatory Datacorp
Venture Round in 2007
Regulatory DataCorp, Inc. is a provider of governance, risk, and compliance solutions, primarily catering to Fortune 100 companies across diverse industries. Established in 2002 and headquartered in King of Prussia, Pennsylvania, with an additional office in Singapore, the company specializes in delivering precise risk alerts and ongoing monitoring to enhance protection and performance. Its range of services includes anti-money laundering, know your customer, anti-bribery and corruption, and supplier due diligence. The company serves a wide array of sectors, including banking, insurance, e-commerce, energy, automotive, and technology, assisting financial institutions and high-risk corporations in achieving superior risk-screening outcomes while ensuring regulatory compliance.
Liberty Dialysis
Seed Round in 2002
Liberty Dialysis, LLC, based in Mercer Island, Washington, develops, owns, and operates dialysis clinics across the United States. Founded in 2002, the company is dedicated to providing quality care for patients with chronic kidney disease through a comprehensive approach that includes outreach programs and home dialysis options. Liberty Dialysis emphasizes patient education, aiming to inform patients, their families, and the community about kidney health. The company operates clinics in multiple states, including Alaska, California, Colorado, Connecticut, Delaware, Hawaii, Idaho, Indiana, Maryland, Michigan, Nevada, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Texas, Utah, Virginia, West Virginia, and Wisconsin. As of 2012, Liberty Dialysis operates as a subsidiary of Fresenius Medical Care AG & Co. KGaA.
TravelClick
Venture Round in 2001
TravelClick is a provider of cloud-based software solutions designed for hoteliers globally. The company offers a comprehensive suite of reservation solutions, including iHotelier, which encompasses a central reservation system, web and mobile booking engines, and global distribution systems to enhance hotel visibility across various channels. TravelClick also delivers business intelligence tools such as Rate360 for rate comparisons and Demand360 for in-depth market analysis. Additionally, its media solutions focus on driving bookings through travel agent media, display marketing, and pay-per-click advertising. The company supports its clients with web development services, including custom websites, search engine optimization, and customer relationship management tools. Founded in 1987 and headquartered in New York City, TravelClick has expanded its presence with offices in key locations worldwide, including Barcelona, Dubai, and Tokyo, serving both independent and chain hotels.
TravelClick
Private Equity Round in 1999
TravelClick is a provider of cloud-based software solutions designed for hoteliers globally. The company offers a comprehensive suite of reservation solutions, including iHotelier, which encompasses a central reservation system, web and mobile booking engines, and global distribution systems to enhance hotel visibility across various channels. TravelClick also delivers business intelligence tools such as Rate360 for rate comparisons and Demand360 for in-depth market analysis. Additionally, its media solutions focus on driving bookings through travel agent media, display marketing, and pay-per-click advertising. The company supports its clients with web development services, including custom websites, search engine optimization, and customer relationship management tools. Founded in 1987 and headquartered in New York City, TravelClick has expanded its presence with offices in key locations worldwide, including Barcelona, Dubai, and Tokyo, serving both independent and chain hotels.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.